Literature DB >> 22105767

The seventh ring: exploring TRAF7 functions.

Tiziana Zotti1, Pasquale Vito, Romania Stilo.   

Abstract

Tumor necrosis factor receptor-associated factors (TRAFs) have been discovered and characterized by their capacity to link tumor necrosis factor receptors (TNFR) family proteins to signaling pathways that transduce the cellular effects mediated by TNF family ligands. There are seven known mammalian TRAF proteins (TRAF1-7), that share a domain organization made of a modular structure, characteristic of adaptor proteins whose function is to link structurally dissimilar factors. Functionally, TRAF proteins mediate the assembly of cytoplasmic signal transducers and regulatory molecules downstream of receptors complexes. Despite the similarities in the signaling pathways activated by the different TRAF proteins, each appears to play distinct physiological roles. TRAF7 is the last member of the TRAF family that has been identified. Yet, the functional characterization of TRAF7 presents some aspects still obscure and poorly defined, making this protein arguably the most mysterious member of the family. In fact, recent data indicate that TRAF7 is involved in signal transduction pathways that lead either to activation or repression of NF-κB transcription factor. In addition, TRAF7 regulates activation of cellular stress pathways, as well as unconventional ubiquitination events and differentiation of muscle tissue. In this review, we try to summarize the most recent advances in our understanding of TRAF7 function and the biological processes of this protein is involved in.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22105767     DOI: 10.1002/jcp.24011

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.

Authors:  Jara K Brenke; Grzegorz M Popowicz; Kenji Schorpp; Ina Rothenaigner; Manfred Roesner; Isabel Meininger; Cédric Kalinski; Larissa Ringelstetter; Omar R'kyek; Gerrit Jürjens; Michelle Vincendeau; Oliver Plettenburg; Michael Sattler; Daniel Krappmann; Kamyar Hadian
Journal:  J Biol Chem       Date:  2018-06-27       Impact factor: 5.157

2.  De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.

Authors:  Mari J Tokita; Chun-An Chen; David Chitayat; Ellen Macnamara; Jill A Rosenfeld; Neil Hanchard; Andrea M Lewis; Chester W Brown; Ronit Marom; Yunru Shao; Danica Novacic; Lynne Wolfe; Colleen Wahl; Cynthia J Tifft; Camilo Toro; Jonathan A Bernstein; Caitlin L Hale; Julia Silver; Louanne Hudgins; Amitha Ananth; Andrea Hanson-Kahn; Shirley Shuster; Pilar L Magoulas; Vipulkumar N Patel; Wenmiao Zhu; Stella M Chen; Yanjun Jiang; Pengfei Liu; Christine M Eng; Dominyka Batkovskyte; Alberto di Ronza; Marco Sardiello; Brendan H Lee; Christian P Schaaf; Yaping Yang; Xia Wang
Journal:  Am J Hum Genet       Date:  2018-06-28       Impact factor: 11.025

3.  Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions.

Authors:  Akihito Oya; Eri Katsuyama; Mayu Morita; Yuiko Sato; Tami Kobayashi; Kana Miyamoto; Toru Nishiwaki; Atsushi Funayama; Yoshinari Fujita; Takashi Kobayashi; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2017-12-22       Impact factor: 2.626

4.  Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.

Authors:  Matthieu Peyre; Loïc Feuvret; Marc Sanson; Soledad Navarro; Anne-Laure Boch; Hugues Loiseau; Michel Kalamarides
Journal:  J Neurooncol       Date:  2017-05-23       Impact factor: 4.130

Review 5.  Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases.

Authors:  Sabrina Fechtner; David A Fox; Salahuddin Ahmed
Journal:  Rheumatology (Oxford)       Date:  2017-07-01       Impact factor: 7.580

6.  Molecular and translational advances in meningiomas.

Authors:  Suganth Suppiah; Farshad Nassiri; Wenya Linda Bi; Ian F Dunn; Clemens Oliver Hanemann; Craig M Horbinski; Rintaro Hashizume; Charles David James; Christian Mawrin; Houtan Noushmehr; Arie Perry; Felix Sahm; Andrew Sloan; Andreas Von Deimling; Patrick Y Wen; Kenneth Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2019-01-14       Impact factor: 12.300

7.  Structural biology study of human TNF receptor associated factor 4 TRAF domain.

Authors:  Fengfeng Niu; Heng Ru; Wei Ding; Songying Ouyang; Zhi-Jie Liu
Journal:  Protein Cell       Date:  2013-08-27       Impact factor: 14.870

Review 8.  TRAF3 as a powerful and multitalented regulator of lymphocyte functions.

Authors:  Gail A Bishop
Journal:  J Leukoc Biol       Date:  2016-05-06       Impact factor: 4.962

9.  Multi-suture craniosynostosis in c.1570C>T (p.Arg524Trp) mutated TRAF7: a case report.

Authors:  Sarut Chaisrisawadisuk; Ajay Taranath; Jonathan Azzopardi; Mark H Moore
Journal:  Childs Nerv Syst       Date:  2021-07-10       Impact factor: 1.475

10.  Grouper TRAF4, a Novel, CP-Interacting Protein That Promotes Red-Spotted Grouper Nervous Necrosis Virus Replication.

Authors:  Siting Wu; Mengshi Sun; Xin Zhang; Jiaming Liao; Mengke Liu; Qiwei Qin; Jingguang Wei
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.